“We are not, at the moment, limited by ideas. We are not limited by scientific opportunities. We are not limited by talent. We are, unfortunately, limited by resources to be able to move this Enterprise forward at the pace that it could take.” Frances S. Collins M.D. , Ph.D.
Mr. Collins has his finger on the pulse of this situation. Mr. Collins, a Geneticist, is the Director of the National Institute of Health.
Personally, trying to remain positive, left aside, and focusing on how I view the reality of our current situation, this is my opinion.
Treatment or a cure for alzheimer’s disease may have as many as ten viable theories, but we may have research dollars to fully examine only two or three.
We need more dollars or a lot of luck, or maybe some of both.
The Alzheimer’s Association estimated that alzheimer’s disease cost America $259 billion dollars in 2017, and less than $1.3 billion was marked for research.
Another personal observation: The Sense of Urgency, in the public, in the press and coming from our legislative bodies doesn’t feel strong. The Sense of Urgency amongst Advocates is to be admired.